HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$15.38
Day range
$13.56 - $15.43
Year range
$4.88 - $19.58
Market cap
300.71M USD
Avg Volume
42.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.47M | 382.27% |
Net income | -9.31M | -327.46% |
Net profit margin | — | — |
Earnings per share | -0.71 | — |
EBITDA | -10.46M | -382.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 151.26M | 1,414.27% |
Total assets | 157.02M | — |
Total liabilities | 6.34M | — |
Total equity | 150.69M | — |
Shares outstanding | 21.70M | — |
Price to book | 2.21 | — |
Return on assets | -22.32% | — |
Return on capital | -23.34% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.31M | -327.46% |
Cash from operations | -11.39M | -420.00% |
Cash from investing | -112.62M | -2,252,380.00% |
Cash from financing | 88.88M | — |
Net change in cash | -35.14M | -1,500.77% |
Free cash flow | -8.13M | — |
About
Founded
2017
Website
Employees
26
